Le zoning Wavre Nord a été bloqué en partie à partir de 3 h 45 du matin dans le cadre de la grève nationale organisée ce ...

Le conseil d’entreprise extraordinaire vient de se terminer chez GSK sur le site de Wavre. La direction a annoncé aux syndicats son intention de supprimer 170 postes d'ici deux ans au niveau ...

C’est devant un parterre de personnalités politiques et de responsables de la célèbre entreprise biopharmaceutique que GSK Wavre a lancé le chantier de construction de sa nouvelle unité de ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya. The shot protects ...

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its own. The British Big Pharma has filed depemokimab for FDA approval ...

GSK est également présent en Belgique. Le groupe emploie 9.000 personnes sur trois sites de production de vaccins en Wallonie (Wavre, Rixensart et Gembloux), parmi lesquels se trouve le siège ...

As a leading developer of vaccines, GSK has a part to play in this, with experts who are well positioned to provide insights into the vaccines of today, and those that are to come. Disease burden ...

GSK’s vaccine portfolio. GSK’s portfolio of more than 20 marketed vaccines, one of the industry’s broadest, protects people against diseases such as meningitis, shingles, polio, measles ...